
Laurus Labs (LAURUSLABS) Share Price Rises 4.02% to Rs 2,306.10 in Today's Trade
Updated: 17 Nov 2026 • 12:30 pm
Posted by:

Laurus Labs Share Price rose to Rs 2,306.10 as of 12:22 PM IST on 17 November 2026, a gain of 4.02% over the previous close of Rs 2,217.05. The price rise adds Rs 89.05 per share and lifts the company's market capitalisation to Rs 1,30,755.56 crore, according to latest Univest data.
The stock opened at Rs 2,221.00 and has traded between Rs 2,218.00 and Rs 2,307.90 so far, which places Laurus Labs Share Price Today close to the top of its intraday range. Laurus Labs operates in the Pharmaceuticals and Drugs industry within the Healthcare sector.
Laurus Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,306.1 |
| Previous Close | Rs 2,217.05 |
| Today's Move | Rs 89.05 (+4.02%) |
| Open | Rs 2,221 |
| High | Rs 2,307.9 |
| Low | Rs 2,218 |
| Market Capitalisation | Rs 1,30,755.56 crore |
| Market Cap Category | Large Cap |
Laurus Labs Ltd. (LAURUSLABS) rose to Rs 2,306.1 from the previous close of Rs 2,217.05, a move of Rs 89.05 or 4.02%. The stock opened at Rs 2,221, reached a high of Rs 2,307.9, recorded a low of Rs 2,218.
Laurus Labs Share Price Today is Rs 2,306.10, up Rs 89.05 or 4.02% from the previous close of Rs 2,217.05. The stock opened at Rs 2,221.00, touched a low of Rs 2,218.00 and reached a high of Rs 2,307.90 as of 12:22 PM IST. That is the Laurus Labs price rise in brief.
The opening level of Rs 2,221.00 was only slightly above the previous close, so most of the gain in Laurus Labs Share Price came after the open. The day low of Rs 2,218.00 also sits above the previous close of Rs 2,217.05, which means the Laurus Labs stock gaining today has traded above yesterday's reference level throughout the period covered so far.
The latest Laurus Labs Share Price Update therefore shows a stock moving within a range bounded by Rs 2,218.00 and Rs 2,307.90, with a market capitalisation of Rs 1,30,755.56 crore. The reported developments around the company and the fundamental picture behind Laurus Labs Share Price Today follow in the next sections.
Why Laurus Labs Ltd. (LAURUSLABS) May Be Moving Today
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,30,755.56 crore |
| P/E Ratio | 89.4x |
| P/B Ratio | 19.77x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 24.8 |
| Book Value Per Share | Rs 112.17 |
| Dividend Yield | 0.09% |
Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 89.4x, P/B 19.77x, ROE 18.31%, ROCE 18.2%. These ratios show where the company stands today and are not a call to buy or sell.
Laurus Labs Ltd. has a market capitalisation of Rs 1,30,755.56 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 89.4x, P/B at 19.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 24.8, book value per share of Rs 112.17, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.46x, median ROE of 11.33%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 89.4x |
| Benchmark Median P/E | 30.46x |
| Benchmark Average P/E | 52.1x |
| Benchmark P/E Range | 2.82x to 1,227.27x |
| Company P/B Ratio | 19.77x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 1,30,755.56 crore |
| Benchmark Median Market Cap | Rs 760.34 crore |
Laurus Labs Ltd. (LAURUSLABS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 89.4x, which is above the benchmark median of 30.46x, a difference of +193.5%. A P/E difference of this kind is a reference point rather than a recommendation.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.33%, a difference of +61.61%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.1%, a difference of +38.93%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,51,290.91 | 40.85 | 5.02 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 3,05,014.11 | 87.71 | 16.39 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,333.2 | 83.99 | 9.71 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,802.71 | 28.37 | 4.26 | 19.69 | 21.39 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,15,016.89 | 41.17 | 2.97 | 11.69 | 13.75 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 89.4x compared with the displayed peer median of 41.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,30,755.56 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- Laurus Labs Share Price rose 4.02% to Rs 2,306.10 against a previous close of Rs 2,217.05.
- The stock has traded between Rs 2,218.00 and Rs 2,307.90 after opening at Rs 2,221.00.
- P/E of 89.4 and P/B of 19.77 sit above the industry medians of 30.46 and 2.92.
- ROE of 18.31% and ROCE of 18.2% are above the industry medians of 11.33% and 13.1%.
- Market capitalisation of Rs 1,30,755.56 crore is above Zydus Lifesciences and Dr. Reddy's Laboratories.
About Laurus Labs
Laurus Labs Ltd. carries the stock symbol LAURUSLABS and is classified in the Pharmaceuticals and Drugs industry within the Healthcare sector. According to latest Univest data, the company has a market capitalisation of Rs 1,30,755.56 crore and is benchmarked against 200 companies in the same industry. Its peers in the comparison above include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Dr. Reddy's Laboratories.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is the Laurus Labs share price today?
Ans. Laurus Labs Share Price is Rs 2,306.10 as of 12:22 PM IST on 17 November 2026, up Rs 89.05 or 4.02% from the previous close of Rs 2,217.05. Market capitalisation stands at Rs 1,30,755.56 crore.
How much has the Laurus Labs share price risen today?
Ans. The Laurus Labs price rise is 4.02%, or Rs 89.05 per share, compared with the previous close of Rs 2,217.05. The stock opened at Rs 2,221.00 and has touched a high of Rs 2,307.90 so far today.
What are the day high and day low of Laurus Labs Share Price?
Ans. Laurus Labs Share Price has touched a high of Rs 2,307.90 and a low of Rs 2,218.00 today, after opening at Rs 2,221.00. The current price of Rs 2,306.10 sits within that range at present.
What is the market capitalisation of Laurus Labs?
Ans. The Laurus Labs market cap is Rs 1,30,755.56 crore according to latest Univest data. That is above the industry median of Rs 760.34 crore and the industry average of Rs 14,899.39 crore across the 200-company benchmark.
What is the P/E ratio of Laurus Labs?
Ans. Laurus Labs has a P/E ratio of 89.4 and a P/B ratio of 19.77. The industry median P/E is 30.46 and the median P/B is 2.92, so both multiples sit above the benchmark medians in the latest Univest figures.
What are the ROE and ROCE of Laurus Labs?
Ans. Laurus Labs reports ROE of 18.31% and ROCE of 18.2%. The industry medians are 11.33% for ROE and 13.1% for ROCE, so both return ratios are above the benchmark medians in the latest Univest figures.
What are the EPS, book value and dividend yield of Laurus Labs?
Ans. EPS is Rs 24.80, book value per share is Rs 112.17 and dividend yield is 0.09%. EPS shows earnings per share, book value shows net worth per share, and the yield reflects the historical payout against the current price.
How does Laurus Labs compare with Sun Pharma and Dr. Reddy's?
Ans. Laurus Labs P/E of 89.4 is above Sun Pharmaceutical Industries at 40.85 and Dr. Reddy's Laboratories at 41.17. Its ROCE of 18.2% is below Sun Pharmaceutical Industries at 19.11% but above Dr. Reddy's Laboratories at 13.75%.
Track Laurus Labs Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Users can track the live Laurus Labs Share Price on Univest, along with fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights. The Univest stock page brings Laurus Labs Share Price Today, peer positions and sector benchmarks together in one place, so that changes in the figures discussed above can be followed as the trading day progresses.
Recent Articles

Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
18 November 2026

V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
18 November 2026

Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
18 November 2026

Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
Mahanadi Coalfields IPO Opens 19 November: Rs 129 to Rs 136 Price Band, Rs 8,981 Crore Offer for Sale and a Coal India Unit Valued at About 8.4 Times Earnings

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





